Prognostic value of systemic inflammatory index (SII) in neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT)

被引：0
作者：
Teran Brage, E. [1 ]
Reguera Puertas, P. [1 ]
Campana-Diaz, E. [2 ]
Navarro Martin, M. [1 ]
Garcia Talavera, P. [2 ]
Rama Alonso, S. [2 ]
Lopez Gutierrez, A. [1 ]
Roldan Ruiz, J. [1 ]
Garijo Martinez, M. D. C. [1 ]
Morchon Araujo, D. [1 ]
Posado-Dominguez, L. [1 ]
Redondo Gonzalez, J. C. [1 ]
Diaz Sanchez, P. [1 ]
Pablo Martin, E. [1 ]
Felix, L. C. [1 ]
Lozano Mejorada, R. [1 ]
Fonseca Sanchez, E. [1 ]
机构：
[1] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain
[2] Univ Hosp Salamanca, Nucl Med Dept, Salamanca, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1222
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1163P
引用
收藏
页码：S758 / S759
页数：2
相关论文
共 50 条
  • [21] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [22] Peptide receptor radionuclide therapy (PRRT) of midgut neuroendocrine tumors: assessment of quality of life
    Marinova, Milka
    Muecke, Martin
    Fischer, Felix
    Essler, Markus
    Cuhls, Henning
    Radbruch, Lukas
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [23] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives
    Baum, Richard P.
    Puranik, Ameya D.
    Kulkarni, Harshad R.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 151 - 158
  • [24] Single Institution Experience with Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ninatti, G.
    Girod, B.
    Ferri, V
    Guja, K.
    Song, H.
    Kunz, P.
    Fisher, G.
    Lagaru, A.
    Mari, Aparici C.
    NEUROENDOCRINOLOGY, 2020, 110 : 253 - 253
  • [25] Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET)
    Duan, Heying
    Ninatti, Gaia
    Girod, Bradley
    Ferri, Valentina
    Kunz, Pamela L.
    Fisher, George A.
    Moradi, Farshad
    Davidzon, Guido Alejandro
    Franc, Benjamin Lewis
    Iagaru, Andrei
    Mari, Carina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [26] Initial Experience With Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors (NETS) at a Tertiary Care United States Center
    Heckert, Jason
    Botterbusch, Samuel
    Kipnis, Sarit
    Bennet, Bonita
    Creamer, Caroline
    Alderson, Alice
    Eads, Jennifer
    Soulen, Michael
    Pryma, Daniel
    Mankoff, David
    Metz, David
    Katona, Bryson
    PANCREAS, 2020, 49 (03) : 470 - 471
  • [27] Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Abou Jokh Casas, Estephany
    Martinez, Nieves Purificacion
    Herranz, Urbano Anido
    Cabezas Agricola, Jose Manuel
    Ferreiro, Silvia Varela
    Maseda, Alberto Carral
    Calvo, Ovidio Fernandez
    Mato Mato, Jose Antonio
    Seoane, Zulema Nogareda
    Martinez de LLano, Sofia Rodriguez
    Varela, Maria Quindos
    Baron, Francisco
    Fonseca, Omar Rodriguez
    Castineira, Antia Cousillas
    Garcia, Gloria Muniz
    De Matias Leralta, Jose Maria
    Catalina, Pablo Fernandez
    Cameselle Teijeiro, Jose Manuel
    Bernardez, Beatriz
    Nunez, Virginia Pubul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [28] Immediate Adverse Effects of Peptide Receptor Radionuclide Therapy (PRRT) Administration in Patients with Neuroendocrine Tumors (NETs): A Single Institution Review
    Wee, C.
    Dundar, A.
    Packard, A.
    Kendi, A. T.
    Eiring, R.
    Hobday, T.
    Halfdanarson, T.
    NEUROENDOCRINOLOGY, 2020, 110 : 277 - 277
  • [29] Hepatotoxicity From Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs) Patients With Very High Liver Tumor Burden
    Gococo-Benore, Denise A.
    Parent, Ephraim
    Sharma, Akash
    Accurso, Joseph
    Yang, Ming
    Kendi, Ayse Tuba
    Sonbol, Bassam
    Halfdanarson, Thorvardur R.
    Starr, Jason S.
    PANCREAS, 2022, 51 (03) : E47 - E47
  • [30] Efficacy and tolerability of peptide receptor radionuclide therapy (PRRT) in advanced metastatic bronchial neuroendocrine tumours (NETs)
    Mirvis, Eitan
    Toumpanakis, Christos
    Mandair, Dalvinder
    Gnanasegaran, Gopinath
    Caplin, Martyn
    Navalkissoor, Shaunak
    LUNG CANCER, 2020, 150 : 70 - 75
12345